Justine Kent

机构：Artistic Realization Technologies

发表论文 72 篇 · 总被引 4828 次 · h-index 35

代表论文

• A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia (2020 · New England Journal of Medicine · 被引 292)
• The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman’s disease (2017 · Brain Behavior and Immunity · 被引 97)
• Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment (2016 · Journal of Psychiatric Research · 被引 94)
• The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder (2019 · Translational Psychiatry · 被引 85)
• The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia (2019 · Journal of Psychopharmacology · 被引 74)
• Clinical Relevance of Sleep Duration: Results from a Cross-Sectional Analysis Using NHANES (2016 · Journal of Clinical Sleep Medicine · 被引 66)